(Hypersensitivity pneumonitis)
6,648 results
  • [Forced oscillation technique in the diagnosis of fibrotic phenotype interstitial lung diseases]. [Journal Article]
    Ter Arkh. 2026 May 02; 98(4):209-216.Nekludova GV, Trushenko NV, … Avdeev SNTA
  • CONCLUSIONS: The oscillometry parameter ΔX5 and the Kco index from diffusing capacity measurement are independent predictors of a fibrotic phenotype in patients with ILD. The combination of these functional parameters improves diagnostic capabilities for detecting fibrotic changes. The FOT method provides clinically important information in patients with ILD and restrictive impairment.
  • Intravascular lymphoma mimicking hypersensitivity pneumonitis: A case report. [Case Reports]
    Respir Investig. 2026 Apr 18; 64(3):101427. [Online ahead of print]Ozawa T, Okamori S, … Nakachi IRI
  • Intravascular large B-cell lymphoma (IVLBCL) is a rare and often fatal malignancy that presents with non-specific pulmonary symptoms and abnormal imaging findings. We report a unique case of IVLBCL in a 73-year-old man who initially presented with fever and bilateral ground-glass opacities on computed tomography that mimicked hypersensitivity pneumonitis. The symptoms temporarily improved with en…
  • T Cell Receptor Sharing in Hypersensitivity Pneumonitis. [Journal Article]
    Comput Struct Biotechnol J. 2026; 2026(1):0002.Sendama W, Funston W, … Simpson AJCS
  • Hypersensitivity pneumonitis (HP) is characterized by an excessive pulmonary T cell response after exposure to inhaled antigens. Antigen avoidance is the best treatment, but in most cases, an antigen cannot be identified. Profiling antigen-specific T cell responses in HP may provide a strategy to identify causative antigens. We used public RNA sequencing data and reconstructed T cell receptor (TC…
  • Treatable traits in interstitial lung disease: towards precision medicine. [Review]
    Thorax. 2026 Apr 03. [Online ahead of print]Avitzur N, Marinescu DC, … Ryerson CJT
  • CONCLUSIONS: Pharmacotherapy of ILD has previously focused on a morphology-based treatable traits approach that uses various clinical, laboratory, radiological and pathological clues to suggest a preferred treatment. We describe this approach and highlight specific questions that need to be addressed in future studies as we move toward a precision-based approach to patient management.